Newsworthy
FDA Approvals, News & UpdatesNewsworthyWeb Exclusives
Web Exclusives – October 15, 2019
In the past week, the US Food and Drug Administration (FDA) has released 2 public announcements related to the use of vaping products.
FDA Approvals, News & UpdatesLymphomaNewsworthy
August 2019 Vol 5 No 4 – August 27, 2019
In June 2019, the FDA approved a new type of immunotherapy called Polivy, for use in combination with other drugs, in patients with previously treated diffuse large B-cell lymphoma (DLBCL), offering new options for patients whose cancer has returned.
FDA Approvals, News & UpdatesLeukemiaNewsworthy
October 2018 Vol 4 No 5 – October 17, 2018
In July 2018, the FDA approved Tibsovo (ivo-sidenib; from Agios Pharmaceuticals), the first IDH1 inhibitor, for the treatment of adults with relapsed (returning) or refractory (not responding to treatment) acute myeloid leukemia (AML) and a susceptible IDH1 genetic mutation.